Judge Pens Beautiful Ode To Knowledge, The Founders & Modern America, Against FDA/Pfizer

Judge Pens Beautiful Ode To Knowledge, The Founders & Modern America, Against FDA/Pfizer

In his ruling the Judge wrote (PDF):

“Open government is fundamentally an American issue”—it is neither a Republican nor a Democrat issue.2 As James Madison wrote, “[a] popular Government, without popular information, or the means of acquiring it, is but a Prologue to a Farce or a Tragedy; or, perhaps, both. Knowledge will forever govern ignorance: And a people who mean to be their own Governors, must arm themselves with the power which knowledge gives.”3 John F. Kennedy likewise recognized that “a nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.”4 And, particularly appropriate in this case, John McCain (correctly) noted that “[e] xcessive administrative secrecy . . . feeds conspiracy theories and reduces the public’s confidence in the government.”5


United States District Judge Mark T. Pittman, United States District Court For The Northern District Of Texas Fort Worth Division Ordered the FDA to produce ‘ “[a]ll data and information for the Pfizer Vaccine enumerated in 21 C.F.R. § 601.51(e) with the exception of publicly available reports on the Vaccine Adverse Events Reporting System” from the Food and Drug Administration (“FDA”). ‘ at a rate of 55,000 pages per 30 day period, expected to take slightly over 8 months.

The FDA/Pfizer originally said they could produce the data at a rate of 500 pages per month, which would take approximately 75 years to produce all the demanded documents.

The Order:
“Accordingly, having considered the Parties’ arguments, filings in support, and the applicable law, the Court ORDERS that:

  1. The FDA shall produce the “more than 12,000 pages” articulated in its own proposal, see ECF No. 29 at 24, on or before January 31, 2022.
  2. The FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.
  3. To the extent the FDA asserts any privilege, exemption, or exclusion as to any responsive record or portion thereof, FDA shall, concurrent with each production required by this Order,produce a redacted version of the record, redacting only those portions as to which privilege, exemption, or exclusion is asserted.”

Leave a Reply

Your email address will not be published.